Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Vrieso 20 Esomeprazole Tablet 20 mg
Vrieso 20, provided by Lexaro Healthcare, contains 20 mg of Esomeprazole in each tablet. This formulation is designed to provide effective treatment for acid-related stomach and esophagus problems, such as gastroesophageal reflux disease (GERD).
Uses of Vrieso 20 Esomeprazole Tablet 20 mg
Vrieso 20 is primarily prescribed for the treatment of gastroesophageal reflux disease (GERD). It is also used to treat other conditions involving excessive stomach acid, such as Zollinger-Ellison syndrome, and to promote healing of erosive esophagitis. Additionally, it can be used in combination with antibiotics to treat certain types of ulcers caused by bacterial infection.
Benefits of Vrieso 20 Esomeprazole Tablet 20 mg
Provides effective relief from symptoms of gastroesophageal reflux disease (GERD).
Helps in the healing of erosive esophagitis.
Reduces stomach acid production for better digestive health.
Can be used to treat and prevent ulcers caused by Helicobacter pylori.
Convenient once-daily dosing for improved patient compliance.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Vrieso 20 Esomeprazole Tablet 20 mg
Esomeprazole is a proton pump inhibitor (PPI). It works by irreversibly inhibiting the H+/K+ ATPase enzyme system of the gastric parietal cells, which blocks the final step of acid production in the stomach. This reduction in stomach acid helps to relieve symptoms, allows healing of acid-related damage, and prevents further damage.